Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	194.62M
Revenue (ttm)	288.76M
Net Income (ttm)	5.47M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	35.59
Forward PE	18.05
Dividend	0.03 (1.15%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	290
Open	2.910
Previous Close	2.910
Day's Range	2.910 - 2.910
52-Week Range	2.500 - 3.380
Beta	0.92
RSI	33.19
Earnings Date	Nov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,437
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial numbers in EUR